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Atomic force microscopy (AFM) was used to locate CD20 molecules on the surface of lymphoma Raji cells. Rituximab (a mono-
clonal antibody against CD20) molecules were linked onto the AFM tip via a polyethylene glycol (PEG) linker. Raji cells were 
adsorbed onto glass slides coated with poly-L-lysine. First, the CD20 distribution in a local area of the cell surface was visualized 
using the AFM lift scan mode. Second, 16 × 16 force curves were obtained from the same cell area to construct the CD20-  
rituximab binding force map. Finally, free rituximab was added to block the CD20 molecules on the cell surface and the lift phase 
image and CD20-rituximab force map were obtained again. The experimental results indicated that when the lift height was great-
er than the length of the PEG linker, no recognition sites were observed in the lift phase image. However, as the lift height de-
creased to the length of the PEG linker, some recognition sites were observed in the lift phase image and these sites were general-
ly consistent with the pixels in the force map. After blocking, both the recognition sites in the lift phase image and the gray pixels 
in the binding force map decreased markedly. These results can improve our understanding of the distribution of protein mole-
cules on the cell surface and facilitate further investigations into cellular functions. 
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Cells are the basic unit of living organisms. There are more 
than 100 trillion cells in the human body. These cells con-
stitute the various tissues and organs, and have different 
morphologies and functions. In the human body, these cells 
do not work separately. They interact with their environ-
ment (other cells or the extracellular matrix) via their sur-
faces to regulate their own and other cells’ behaviors [1]. 
On the cell surface, there are many different types of recep-
tors that can recognize specific ligands in the extracellular 
environment. Cells use these receptors to communicate with 
their environment [2]. With the rapid development of cellu-
lar and molecular biology, it has become increasingly ap-
parent that these receptors do not operate separately but are 
components of well-organized multimolecular assemblies 
on the cell surface [3]. Transient associations between the 
various molecules within microdomains on the cell surface 
can have a direct impact on the biological function of these 
molecules [4]. Therefore, understanding how these mole-
cules localize, assemble and interact on the surface of living 
cells is important for elucidating the underlying mecha-
nisms of cellular functions [4]. Several techniques can be 
used to observe the dynamic behaviors of individual mole-
cules, including fluorescence microscopy, optical tweezers, 
electron microscopy, X-ray crystallography and nuclear 
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magnetic resonance (NMR) [5,6]. For fluorescence micros-
copy, labeling may interfere with the molecular dynamics 
[5]; for optical tweezers, local heating can influence enzy-
matic activity and change the local viscosity of the medium 
[7]; while for the other techniques, the obtained structures 
are essentially static [6]. In recent years, atomic force mi-
croscopy (AFM) has attracted scientists’ attention because 
of its outstanding capacity for observing the behaviors of 
single molecules under physiological conditions [8,9]. AFM 
achieves nanometer resolution and can work in various en-
vironments, including the liquids necessary for living cells. 
By tethering antibodies or ligands onto the AFM tip, spe-
cific molecules (receptors or antigens) on the cell surface 
can be located by using either binding force mapping [10] 
or dynamic force recognition mapping [11]. In this work, 
we combined the AFM lift scan method and the binding 
force mapping method to locate CD20 molecules on the 
surface of lymphoma Raji cells. 
The principles of the AFM lift scan method [12] and the 
force mapping method [10] are shown in Figure 1. Rituxi-
mab molecules were linked onto the AFM tip. In the lift 
scan mode, the probe scans the surface twice. The first scan 
(called the main scan) is performed in the normal tapping 
mode to obtain the topography. Then, the tip is lifted to a 
constant height and the second scan (called the lift scan) is 
performed along the main scan trace. Therefore, the dis-
turbance of the cellular topography is eliminated, and the 
lift scan trace is only influenced by the specific anti-
body–antigen binding between CD20 on the cell surface and 
rituximab on the tip. When rituximab binds to CD20, the 
amplitude of the cantilever changes and leads to changes in 
the phase information of the lift scan phase image, and 
hence CD20 on the cell surface can be visualized in the lift 
scan image. For force mapping, the local area of the cell 
surface is divided into an array of small areas (for example,  
 
 
Figure 1  The principles of the AFM lift scan mode and force mapping.  
(a) Lift scan mode. The lift scan is performed along the main trace to elim-
inate the influence of cellular topography. (b) Force mapping method. An 
array of force curves is obtained to construct the binding force map. 
16 × 16), and then the functionalized probe is used to obtain 
a force curve for each small area. If CD20 molecules are 
present in the small area, then abrupt peaks may appear in 
the retraction portion of the force curve [13]. If CD20 mol-
ecules are not present in the small area, then the force curve 
is flat. The CD20-rituximab binding force for each small 
area is then computed from these force curves (if there is no 
abrupt peak in the force curve, then the binding force is in-
dicated as 0). By normalizing these force values into the 
range of 0–255, the force map was then constructed using 
image processing software. 
Raji cells (a Burkitt’s lymphoma cell line) and Hut cells 
(a T lymphoma cell line) were used in this study. The cells 
were cultured at 37°C (5% CO2) in RPMI-1640 culture me-
dium containing 10% fetal bovine serum for 24 h before 
experiments. Cells were harvested by centrifugation at 1000 
r/min for 5 min. Then, the cells were dropped onto poly-L- 
lysine-coated glass slides and fixed with 4% paraformalde-
hyde. The PEG linker, NHS-PEG2000-MAL (JenKem 
Company, China), was used to link rituximab molecules 
onto the AFM tip. The functionalization procedure followed 
an established procedure [13] and RBITC-labeled goat an-
ti-human IgG was used to verify whether rituximab mole-
cules had been linked onto the AFM tip. In brief, the func-
tionalized probe was placed into a Petri dish containing 
phosphate buffered saline (PBS), to which RBITC-labeled 
goat anti-human IgG was then added. After washing the 
unbound IgG, the probe was placed onto the stage of the 
fluorescence microscope (Nikon Ti-U-FL, Japan) to observe 
the fluorescence of the probe. 
AFM imaging and measurements were performed using a 
Dimension 3100 AFM (Veeco Company, Santa Barbara, 
CA, USA) in PBS at room temperature. The spring constant 
of the cantilever (with a normal spring constant of 0.01 N/m) 
was calibrated using the thermal noise method. The func-
tionalized probe was placed onto a Raji cell under the guid-
ance of the AFM’s optical microscope. First, the normal 
tapping mode was performed in a local area (3 μm) of the 
cell surface to obtain the cell topography. Then, the lift scan 
mode was performed at different lift heights (50 and 20 nm). 
Second, the 16 × 16 force curves were obtained from the 
same area to produce the CD20-rituximab binding force 
map. Then, free rituximab solution was added and about 30 
min later, the normal tapping mode, lift scan mode, and 
force curves were obtained again. Also, the lift scan and 
force curve obtained with the functionalized probe were 
performed on Hut cells, which do not express CD20 mole-
cules. 
Figure 2 shows the results of mapping CD20 molecules 
on the Raji cell surface by combing the lift scan mode with 
binding force mapping. Figure 2(a) shows a fluorescence 
image of the functionalized probe. The functionalized probe 
exhibited bright fluorescence after staining with RBITC- 
labeled IgG, indicating that rituximab had been linked onto 
the AFM tip. In the optical image of the functionalized 
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Figure 2  Analysis of the distribution of CD20 on the lymphoma cell surface. (a) Fluorescence image of the functionalized probe. Inset, optical image of 
the functionalized probe. (b)–(d) are AFM images acquired in the normal tapping scan mode. (b) Height image. (c) Phase image. (d) Amplitude image. 
(e)–(h) are AFM images acquired in the lift scan mode. (e) Phase image of the main scan with a lift height of 50 nm. (f) Phase image of the lift scan with a 
lift height of 50 nm. (g) Phase image of the main scan with a lift height of 20 nm. (h) Phase image of the lift scan with a lift height of 20 nm. (i) A typical 
force curve. (j) Force map. (k) Overlaying of the phase image (lift scan) and force map. 
probe, the tip is clearly denoted by the circle (Figure 2(a)). 
During the functionalization procedure, both the cantilever 
and the probe tip were coated with antibodies [14] because 
both were made of silicon. Living cells have a soft and dy-
namic surface, which means that the scanning AFM tip can 
deform the cell surface [15]. Therefore, to avoid the defor-
mation of the cell membrane, fixing agents are often used 
[11]. AFM images of the local cell surface obtained in the 
normal tapping mode revealed that the cell surface was 
rough (Figure 2(b)–(d)). Then, the lift scan mode was per-
formed and the images obtained are shown in Figure 2(e)– 
(h). The phase images of the main scan (Figure 2(e) and (g)) 
were almost identical to the phase images obtained in nor-
mal tapping mode (Figure 2(c)). This is because the main 
scan during the lift scan mode is essentially the normal tap-
ping mode. The molecular weight of the PEG linker used 
here is 2000 Daltons (information provided by the supplier). 
The length of a PEG linker with a molecular weight of 800 
Daltons has been determined to be 8 nm [16,17]. Hence, the 
length of the PEG linker used here was about 20 nm. When 
the lift height was higher than the length of the PEG mole-
cule, there was no recognition in the lift scan (Figure 2(f)). 
This is because the rituximab molecules could not contact 
the cell surface. When the lift height approximated the 
length of the PEG molecule, the recognition sites were seen 
in the lift scan, as denoted by the yellow circles in Figure 
2(h). Some sites resembling the recognition sites were also 
seen, as denoted by the red circles in Figure 2(h). These 
sites were not recognition sites because they also appear in 
the phase image with a lift scan height of 50 nm. The cellu-
lar structures in these sites were quite high and may cause 
the changes in the phase signal. 
Then, 16 × 16 force curves were obtained from the same 
area. Figure 2(i) shows a typical force curve with an abrupt 
peak in the retraction curve. From these 256 force curves, 
the CD20-rituximab binding forces were computed and the 
force map of the local cellular area was constructed, as 
shown in Figure 2(j). Overlaying the lift scan image and the 
force map shows that the two images were generally con-
sistent with each other (Figure 2(k)). To verify the specific 
CD20-rituximab binding, two control experiments were 
performed. First, blocking experiments [18] were performed. 
After adding free rituximab, the distribution of the CD20 
molecules was measured again, as shown in Figure 3(a)–(e). 
Very few spots were observed in the lift scan (Figure 3(c)). 
Furthermore, there were few recognition pixels in the force 
map, indicating that the distribution of CD20 molecules on 
the cell surface decreased significantly. This is because the 
added rituximab molecules bound to the CD20 molecules 
and hence masked these CD20 molecules. Then, the lift  
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Figure 3  Control experiments. Detecting the distribution of CD20 molecules on the Raji cell surface after blocking (a)–(e). (a) Height image. (b) Phase 
image of the main scan with a lift height of 20 nm. (c) Phase image of the lift scan with a lift height of 20 nm. (d) Force map. (e) Overlaying of the phase 
image (lift scan) and force map. Performing the lift scan on Hut cells (f, g). (f) Phase image of the main scan with a lift height of 20 nm. (g) Phase image of 
the lift scan with a lift height of 20 nm. (h) A typical force curve obtained on Hut cells. 
scan was performed on Hut cells. No recognition sites were 
seen in the phase image of the lift scan because Hut cells do 
not express CD20 molecules. Also, there were no abrupt 
peaks in the force curve (Figure 3(h)). Hence, the control 
experiments verified the specific molecular binding. 
Since its invention, AFM has become a fascinating tech-
nology for investigating biological systems [19–22]. The 
rapid development of high-speed AFM in recent years has 
allowed researchers to watch single molecules in action in 
real time, directly providing biologists with unprecedented 
amounts of information on functional proteins instead of 
modeling dynamic processes [5,6,9]. When the systems 
being studied become more complex, AFM techniques that 
allow specific recognition of molecules will be vital, be-
cause many proteins do not show distinctive morphological 
features and therefore are indistinguishable from each other 
in an AFM image [5]. Here, we characterized the distribu-
tion of CD20 molecules on the lymphoma cell surface by 
combining the lift scan method with the binding force map-
ping method. However, there is a shortcoming of the lift 
scan method in that the cell surface is rough and corrugated, 
and this morphology may affect antigen-antibody binding. 
Therefore, the recognition image may not include all of the 
CD20 molecules in the cellular area local to the probe. Im-
proving the detection probability of the functionalized AFM 
tip (particularly on living cells) is a challenge that needs to 
be addressed. In summary, CD20 molecules on the lym-
phoma cell surface were located by combing the lift scan 
method with the force mapping method. The experimental 
results validate the effectiveness of the lift scan method and 
facilitate further investigations into cellular functions. 
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